European Union · Question · QUESTION_WRITTEN
E-9-2021-005626
Revision of Regulation 141/2000 on orphan medicinal products to avoid market abuses and regulatory loopholes
Introduced
20 December 2021
Last action
—
Status
answered
Sponsors
—
Subjects
Discovery layer
Source updated
17 February 2022
Records
Official question E-9-2021-005626 from European Union at European Parliament. Dated 20 December 2021. Status: answered.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
7 official files
Revision of Regulation 141/2000 on orphan medicinal products to avoid market abuses and regulatory loopholes
QUESTION_WRITTEN · EN · 5 January 2022
Revision of Regulation 141/2000 on orphan medicinal products to avoid market abuses and regulatory loopholes
QUESTION_WRITTEN · EN · 5 January 2022
Revision of Regulation 141/2000 on orphan medicinal products to avoid market abuses and regulatory loopholes
QUESTION_WRITTEN · EN · 5 January 2022
Answer
QUESTION_WRITTEN_ANSWER · 17 February 2022
Revisión del Reglamento (CE) n.º 141/2000 sobre medicamentos huérfanos para evitar abusos de mercado y lagunas en la regulación
QUESTION_WRITTEN · ES · 5 January 2022
Revisión del Reglamento (CE) n.º 141/2000 sobre medicamentos huérfanos para evitar abusos de mercado y lagunas en la regulación
QUESTION_WRITTEN · ES · 5 January 2022
Revisión del Reglamento (CE) n.º 141/2000 sobre medicamentos huérfanos para evitar abusos de mercado y lagunas en la regulación
QUESTION_WRITTEN · ES · 5 January 2022
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.